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Abstract
Background: Oral squamous cell carcinoma could be preceded by clinically evident oral
potentially malignant disorders (OPMDs). Transformation of OPMDs to cancer has been studied
in several population groups. It is difficult to undertake comparisons across populations due to
variations in the methods of computation of malignancy rates among different studies. The aim of
our study was to estimate the rate of malignant transformation of OPMDs taking into account the
duration of follow-up and to identify the significant factors indicative of malignant potential.
Methods: A total of 148 male patients with OPMDs were included. They were selected among all
consecutive subjects registered at the maxillofacial clinic at a medical hospital in Kaohsiung, Taiwan.
The mean follow up period was 37.8 months.
Results: The malignant transformation rate was highest in subjects diagnosed with oral epithelial
dysplasia. In this group the transformation rate was 7.62 per 100 persons-year. The rate in the
group with verrucous hyperplasia (VH) was 5.21 per 100 persons-year, and in those with
hyperkeratosis or epithelial hyperplasia was 3.26 per 100 persons-year. The anatomical site of
OPMDs was the only statistically significant variable associated with malignancy. The hazard rate
ratio (HRR) was 2.41 times for tongue lesions when compared with buccal lesions.
Conclusion: The reported discrepancies of malignant transformation of OPMDs involve the
follow-up time to cancer development and hence it is preferable to use a time-to-event estimation
for comparisons. We found that malignant transformation of OPMDs involving the tongue was
significantly higher than in other anatomical subsites after adjusting for the clinicopathological type
or lifestyle factors at diagnosis.
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Incidence of oral cancer has been rising in many countries
in the world [1]. The 5-year survival rate for oral cancer
has not significantly improved in the past 30 years and
remains at approximately 50% [2]. Many oral squamous
cell carcinomas are preceded by clinically evident oral
potentially malignant disorders (OPMDs) [3]. It is very
important to prevent malignant change in people diag-
nosed with OPMDs, but the hazard ratios of various
OPMDs are not well known. The OPMDs include hyperk-
eratosis or epithelial hyperplasia, epithelial dysplasia [4-
6], erythroplakia [7] and oral submucous fibrosis (OSF)
[8,9] and their clinical phenotypes are well documented.
hyperkeratosis or epithelial hyperplasia, epithelial dyspla-
sia and OSF are the most common oral mucosal disorders
in the regions where areca quid chewing is prevalent, such
as India, Taiwan, and other Southeast Asian countries [9-
15]. The malignant potential of oral lichen planus (OLP)
remains controversial, because of the absence of univer-
sally accepted diagnosis criteria[16] therefore those diag-
nosed with OLP were not included in this study. The
malignant transformation rates of OPMDs show a great
variation; for example, 10–20% of hyperkeratosis or epi-
thelial hyperplasia, epithelial dysplasia may transform to
cancer and the estimated annual rate is 1.4%–7%
[5,6,12,17]. In 1995, Lumerman reported that 6.6%–36%
of epithelial dysplasias may transform to invasive
SCC[18]. The studies concerning malignant transforma-
tion in OSF have been reported from India [8,9], with a
reported malignant transformation rate of 2.3%–7.6%
during 10–17 years of follow-up [8,9]. In a recent study in
Taiwan [19], the malignant transformation rate of
OPMDs was estimated at 3.02% in an average follow-up
period of 42.6 months, and the transformation rate
ranged from 1.9 to 5.4% for various types of OPMDs.
The malignant transformation of OPMDs to cancer has
been studied in many different populations
[5,6,8,9,12,17-19] and the evidence was reviewed by
Napier & Speight [20]. It is difficult to undertake compar-
isons across populations due to variations in the methods
of computation of malignancy rates among different stud-
ies. The malignant potential of a OPMDs should be a
time-to-event function, not just calculated based on the
number of malignant cases divided by total number of
patients. Generally, a crude calculation by the event itself
may contribute to bias [8,9,18]. This bias is due to the
OPMDs patients with different follow-up durations, and
clearly longer follow-up periods contribute to higher
transformation percentages. Hence, a person-time malig-
nant transformation rate is more accurate in terms of cross
population comparisons.
The risk factors associated with these OPMDs and oral
cancer have been established. Tobacco use, alcohol abuse
and areca quid chewing habits are important risk factors.
The associated factors in the progression of the disease
and malignant transformation of OPMDs have not been
well defined in previous studies. Lesion type
[5,6,8,9,12,17-19], age [6,21], lifestyle habits [5,6,22] and
lesion subsites [23,24] were significant factors related to
malignancy, but the results from different studies vary and
firm conclusions cannot be drawn.
The aim of our study was to estimate the malignant trans-
formation rate by taking into account the varying individ-
ual lengths of follow-up of a cohort of consecutive
subjects diagnosed with OPMDs in Taiwan and to identify
the significant factors contributing to malignant potential
of OPMDs using a time-to-event analysis method.
Methods
In this hospital-based follow-up study a total of 148 male
subjects with OPMDs were included. We searched the files
of all patients admitted at the maxillofacial clinic at a
medical hospital in Kaohsiung, Taiwan from 1986 to
2004. The consecutive subjects with clinicopathological
diagnosis of OPMDs, which including hyperkeratosis or
epithelial hyperplasia, epithelial dysplasia, verrucous
hyperplasia and oral submucous fibrosis (OSF). The
exclusion criteria were:
1. Any patient with OPMD who had not been fol-
lowed-up for more than 6 months
2. Those patients who had oral cancer before the diag-
nosis of OPMDs.
3. The patients who were ever diagnosed as OPMDs
and received prior medical therapy.
4. The duration from OPMDs to oral cancer was less
than 6 months.
No medical or surgical treatments were offered to this
group except habit interventions and repeat biopsy when
indicated clinically during follow up.
The diagnosis of OPMDs and development of SCC during
follow-up were confirmed by histopathology. These histo-
logical diagnoses used here were described in more detail
in a previous report [19]. The diagnostic criteria for the
detection of OPMDs were based on the recommendations
of the WHO [25,26] and the First International Seminar
on 'Oral Leukoplakia'[27]. Verrucous hyperplasia(VH) is
rarely seen in western countries, but is a common type of
OPMD in Taiwan. Yu's [28], described the histological cri-
teria for a diagnosis of verrucous hyperplasia: (1) epithe-
lial hyperplasia with parakeratosis or hyperkeratosis and a
verrucous surface, and (2) no invasion of the hyperplasticPage 2 of 7
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cent normal mucosal epithelium.
During analysis of data on subjects with multiple lesions,
we considered the first diagnosed lesion as the index
lesion. The primary end point of the study was develop-
ment of oral cancer in a existing OPMDs. Each subject had
regular follow-up at approximately three-monthly inter-
vals during the study period.
The information on lifestyle habits, including smoking,
use of alcohol, areca quid and site by lesions were collated
from the clinic records. These data were recorded prospec-
tively during the patients' first visit to our clinic.
Chi-square test was used to compare the distribution of
related factors in OPMDs and in the group with malignan-
cies. Time-to-event analysis involved estimating the prob-
ability that an event will occur at different points in time.
The end point of follow-up in those developing cancer
was the date of detection of oral malignancy, and in those
lost to follow up were coded by the date of last visit, to
arrive at "censored" data. The most common time-to-
event statistical method is the Kaplan-Meier method and
the Cox proportional hazard model. The Kaplan-Meier
estimate was computed to estimate the probability of can-
cer-free survival. The Cox proportional hazards model was
applied to analyze the effect of single and multiple covari-
ates in predicting cancer development.
This study complied with the Helsinki Declaration. The
data in this study were collected after the approval of the
Institutional Review Board of Kaoshiung Medical Univer-
sity Hospital (KMUH-IRB-970157) after obtaining
informed consent.
Results
The mean follow-up period of the cohort of 148 male
patients was 37.8 months. Among these subjects. Buccal,
vestibule and retromolar areas were the most common
locations of these OPMDs, and there were 100 patients
(65.8%) with lesions located in these subsites. There were
21 subjects (13.8%) with lesions on the tongue and 18
(11.8%) on the lip. Histological examination of the initial
biopsy revealed 67 subjects (42.3%) with hyperkeratosis
or epithelial hyperplasia, this being the most common
pathology diagnosis among the study group. Verrucous
hyperplasia (VH) was the second most common lesion,
with 44 subjects (29.7%) in this study. Thirty three sub-
jects had epithelial dysplasia (22.3%) and 4 had OSF
(2.7%).
The profile of the 4 groups showing characteristics of
malignant transformation is shown in Table 1. The malig-
nant transformation rate was highest in the group with
epithelial dysplasia (24.2%), followed by verrucous
hyperplasia (20.0%), and hyperkeratosis or epithelial
hyperplasia (8.6%). In Table 1, the person-time malig-
nant rate was also estimated with consideration given to
the duration of follow-up. The rate of malignant transfor-
mation for those with epithelial dysplasia was 7.6 per 100
persons-year, 5.2 per 100 persons-year in VH, and 3.3 per
100 persons-year in those with hyperkeratosis or epithe-
lial hyperplasia. In our study, none of the subjects with
OSF had malignant change during the follow-up period.
Table 2 shows subject and lifestyle factors related to
malignant transformation in OPMDs. Those older than
45 years of age at their first diagnosis showed a slightly
higher malignant potential than the younger group at first
diagnosis (20.0% vs 11.4%), but age at diagnosis was not
statistically significant. The absence of smoking or chew-
ing habit seemed to have a higher risk for developing
malignancy. The development of malignancy in non-
smokers or non-chewers with OPMDs was about 40%,
which was approximately 3-fold higher than for smokers
or chewers. About 50% of lesions located on the tongue
(11/22) were found to transform, and the rate was signif-
icantly higher than lesions located on other subsites (P <
0.0001).
Figure 1 shows the Kaplan-Meier analysis for cancer-free
survival by different OPMDs. From this analysis, we
found that epithelial dysplasia and VH showed similar
patterns of cancer-free survival. A rapid descending curve
was discovered in the first 2–3 years in all OPMDs. The
Table 1: Malignant Transformation in OPMDs
Age(years)1 Mean Duration(months)2 Duration Range3 Malignancy(%)4 Transformation rate(CI)5
Epithelial dysplasia 46.70(11.51) 38.18(27.90) 6.53–101.2 8 (24.24) 7.62 (2.34–12.90)
Verrucous hyperplasia 46.66(11.11) 41.87(42.47) 6.07–185.5 9 (20.00) 5.21 (1.60–8.82)
Hyperkeratosis or epithelial hyperplasia 42.51(12.98) 32.94(32.81) 6.13–135.23 6 (8.57) 3.26 (0.65–5.87)
OSF 39.50(21.05) 71.13(50.45) 27.27–140.97 0 (0.00) -
1 The average age with standard deviation at first diagnosis
2 The average follow-up duration with standard deviation before malignant event
3 The range of follow-up duration before malignant event
4 The number and proportion of malignant transformation
5 The malignant transformation rate with 95% Confidence Interval (100 persons-year)Page 3 of 7
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epithelial dysplasia and VH were less than 80%, which
meant that the malignant rate of these two OPMDs were
higher than 20%. The 3-year malignant transformation
rate of hyperkeratosis or epithelial hyperplasia was
approximately 10%. Epithelial dysplasia and VH seemed
to show higher malignant potential than hyperkeratosis
or epithelial hyperplasia. Further investigation with Cox
proportional hazard regression analysis was performed
(Table 3). In the multiple regression models, we consid-
ered the effect of age of diagnosis, gender, subsite loca-
tion, lesion type and lifestyle habits on malignant
transformation. We found that after adjusting for other
factors, lesions located on the tongue were found to have
a higher malignant risk, with a hazard ratio (HRR) of 2.41
(1.43, 4.16) when compared to lesions located on the
buccal mucosa. In addition to subsite location, age at
diagnosis and lesion type were also important factors
related to malignancy. Presence of epithelial dysplasia
and VH showed higher malignant risk than hyperkeratosis
or epithelial hyperplasia. HRRs were 1.51 times in epithe-
lial dysplasia and 1.23 times in VH. The malignant risk for
the group diagnosed before 45 years of age was 1.42 times
more than those below 45 years. But the age at diagnosis
and type of OPMD were not with statistically significant
largely due to the small sample size.
Discussion
The present study describes some general features of
OPMDs in a hospital outpatient population in Taiwan.
The buccal, vestibule and retromolar areas were the most
common sites affected. These together accounted for more
than 60% of affected sites. Hyperkeratosis or epithelial
hyperplasia, epithelial dysplasia was the most common
OPMD. About 45% of OPMDs were epithelial dysplasia
and 30% had epithelial dysplasia. In the US, 85% of
OPMDs are hyperkeratosis or epithelial hyperplasia, epi-
thelial dysplasia, and more than two thirds of all oral
hyperkeratosis or epithelial hyperplasia, epithelial dyspla-
sia are found on the lip, buccal mucosa and gingiva. In
most studies from western countries, the predominant
OPMDs sites are the tongue and floor of the
mouth[5,6,29,30]. But studies from India, Taiwan and
other Southeast Asian countries, indicated that the buccal
mucosa is the most common site of premalignancy [9-
11,13,14]. It is suggested that the differences of site distri-
bution and lesion type may be related to different risk fac-
tors in different populations [10,11]. In this study, we
found the mean age at first dignosis of OPMDs was about
45 years. A young age at first diagnosis of OPMDs has also
been reported in previous studies of Taiwan [11,31]. In
comparison the mean age of diagnosis of hyperkeratosis
or epithelial hyperplasia, epithelial dysplasia in reports
from other countries is about 55–60 years [6,18,32]. It is
suggested that OPMDs occurring at a younger age may be
related to subsequent development of oral cancer while
they are still young. This is consistent with the mean age
at diagnosis of oral cancer in Taiwan is about 10 years
younger than in other countries[33].
In the present study, we compared malignant potential of
several common OPMDs. We also took follow-up dura-
tion into account to estimate the malignant transforma-
tion rate and to evaluate related factors of malignancy. In
previous studies, the malignant transformation rate of
hyperkeratosis or epithelial hyperplasia, epithelial dyspla-
sia was reported to be 10–20% and the annual rate was
1.4%–7% [5,6,12,17]. In our study, hyperkeratosis or epi-
thelial hyperplasia, epithelial dysplasia had a malignant
transformation rate from 8% to 24%, and the annual rate
is 3–8 per 100 persons-year. Epithelial dysplasia have the
highest transformation rate, and this is consistent with
previous reports [18,24].
VH has rarely been reported in scientific literature and the
malignant potential of VH has not been examined in
detail. In the hospital clinics in Taiwan, VH has been
noted in areca quid chewers [15]. The annual malignant
transformation rate of VH is about 5.2 per100 persons-
year, and almost 1.5-fold higher than hyperkeratosis or
epithelial hyperplasia. In the context of Taiwan VH
appears an important entitity among OPMDs [19]. The
transformation rate of VH in our study is higher than in
Hsue's study [19]. In this study, none of the OSF patients
showed evidence of malignant transformation. This is
probably because of the small number of patients with




N % N % P value
Age
<=45 years 13 20.00 52 80.00
> 45 years 9 11.39 70 88.61 0.1531
Smoking
No 18 13.64 114 86.36 0.0447
Yes 4 36.36 7 63.64
Alcohol use
No 13 14.13 79 85.87 0.7273
Yes 8 16.33 41 83.67
Areca quid use
No 20 14.49 118 85.51 0.1204
Yes 2 40.00 3 60.00
Location
Buccal2 8 8.25 89 91.75 < 0.0001
Tongue 11 52.38 10 47.62
Other3 3 11.54 23 88.46
1: OSF cases are excluded in this table
2: Including buccal, vestibule and retromolar
3: Including lip, gingiva, palatePage 4 of 7
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comobidity lesion, which is often found coexisting with
other OPMDs [9]. In the present study, few subjects were
first diagnosed as OSF. Due to low prevalence a larger
cohort is needed to examine the malignant profile of OSF.
To compare different malignant transformation patterns
in OPMDs, a follow-up curve was plotted according to the
Kaplan-Meier method. Differences were noted in the three
types of OPMDs entered in the study. During the first 2–3
years of follow-up a higher risk of malignant transforma-
tion was noted, an observation that was also found in Sil-
verman's study [6]. It is suggested that rigorous follow-up
in the first two years after diagnosing OPMDs may be
important in detecting early occurrence of malignancy [6].
The higher risk observed during the earlier phases of fol-
low-up could be due to sampling errors of biopsy diagno-
sis of OPMDs. This needs to be verified in further studies.
It is proposed that studies on the natural history should
exclude any cases transforming within 6 months of biopsy
to allow for sampling errors.
Lesions located on the tongue may have a higher malig-
nant risk, which has also been reported in other stud-
ies[23,24]. Schepman's study, however, showed that there
were no particular oral subsites associated with an
increased risk of oral cancer [5]. The subsite variation in
malignant transformation may need further study. Age is
The Kaplan-Meir curve for cancer free survival by OPMDsFigure 1
The Kaplan-Meir curve for cancer free survival by OPMDs.Page 5 of 7
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tion, which may be related to genetic susceptibility con-
tributing to the phenotype. In studies by Bouquot [21]
and Silverman et al[6], it was reported that the longer the
existence of hyperkeratosis or epithelial hyperplasia, epi-
thelial dysplasia the worse its prognosis.
Shiu et al.'s study in 2000 indicated that betel quid chew-
ing is a significant factor influencing malignant transfor-
mation in hyperkeratosis or epithelial hyperplasia,
epithelial dysplasia[22]. In Schepman's study in 1998 and
Silverman's in 1984 [5,6], the absence of smoking was
associated with an increased risk of malignancy in hyper-
keratosis or epithelial hyperplasia, epithelial dysplasia.
Our findings also confirmed a lack of effect of smoking,
drinking and chewing on OPMDs malignant change, as
these factors were not significant in our study. It may be
said that lifestyle habits play significant roles in the devel-
opment of OPMDs, but one can not state with certainty
that these habits promote malignant transformation of
OPMDs[23]. The lifestyle habits collected in our study
were from the case records of the patients' first visit, and
the prevalence of these habits may be under reported. The
risk factors relating to malignant formation of OPMDs
were not well defined in previous studies. In the present
data, we found that an age older than 45 years, lesions on
the tongue, epithelial dysplasia and VH might be impor-
tant risk factors related to malignancy. The lifestyle habits
may be associated with the development of OPMDs, they
do not appear to affect the prognosis. This may be because
some subjects quit their risk habits following the detec-
tion of an OPMD. Further study is needed to clarify the
trend of lifestyle habits following diagnosis of OPMDs,
and the roles of intervention in the malignant process of
OPMDs.
Significant gender differences were found in oral cancer
cases and OPMDs of Taiwan[10,19,33]. To avoid the con-
fusing etiological effect between genders, only males were
included in the present study.
Conclusion
In conclusion, the importance of certain risk factors, such
as oral subsite, age at diagnosis and type of OPMD that are
associated with an increased chance of malignant trans-
formation of OPMDs in Taiwan are reported here. The
malignant potential of epithelial dysplasia and VH is
much higher than that of hyperkeratosis or epithelial
hyperplasia. Rigorous follow-up is advised in the first 2–3
years after the detection of OPMDs. Finding a lesion
located on the tongue appears to be the most important
factor affecting malignant transformation of OPMDs.
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